RT Journal Article
SR Electronic
T1 RISK FACTORS FOR THE DEVELOPMENT OF HOSPITAL-ACQUIRED PEDIATRIC VENOUS THROMBOEMBOLISM: DEALING WITH POTENTIALLY CAUSAL AND CONFOUNDING RISK FACTORS USING DIRECTED ACYCLIC GRAPH (DAG) ANALYSIS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.17.20153718
DO 10.1101/2020.07.17.20153718
A1 Leonardo R. Campos
A1 Maurício Petroli
A1 Flavio R. Sztajnzbok
A1 Elaine S. Costa
A1 Leonardo R. Brandão
A1 Marcelo G. P. Land
YR 2020
UL http://medrxiv.org/content/early/2020/07/19/2020.07.17.20153718.abstract
AB Introduction Hospital-acquired venous thromboembolism (HA-VTE) in children comprises multiple risk factors that should not be evaluated separately due to collinearity and multiple cause and effect relationships. This is one of the first case-control study of pediatric HA-VTE risk factors using Directed Acyclic Graph (DAG) analysis.Material and Methods Retrospective, case-control study with 22 cases of radiologically proved HA-VTE and 76 controls matched by age, sex, unit of admission, and period of hospitalization. Descriptive statistics was used to define distributions of continuous variables, frequencies, and proportions of categorical variables, with a comparison between cases and controls. Due to many potential risk factors of HA-VTE, a directed acyclic graph (DAG) model was created to identify confounding, reduce bias, and increase precision on the analysis. The final model consisted of a DAG-based conditional logistic regression. The study was approved by the Institutional Review Board (CAAE 58056516.0.0000.5264).Results In the initial univariable model, the following variables were selected as potential risk factors for HA-VTE: length of stay (LOS, days), ICU admission in the last 30 days, LOS in ICU, infection, central venous catheter (CVC), L-asparaginase, heart failure, liver failure and nephrotic syndrome. The final model (table 1) revealed LOS (OR=1.108, 95%CI=1.024-1.199, p=0.011), L-asparaginase (OR=27.184, 95%CI=1.639-450.982, p=0.021), and nephrotic syndrome (OR=31.481, 95%CI=1.182-838.706, p=0.039) as independent risk factors for HA-VTE.Conclusion The DAG-based approach was useful to clarify the influence of confounders and multiple causalities of HA-VTE. Interestingly, CVC placement - a known thrombotic risk factor highlighted in several studies - was considered a confounder, while LOS, L-asparaginase use and nephrotic syndrome were confirmed as risk factors to HA-VTE. Large confidence intervals are related to the sample size, however the results were significant.HighlightsHA-VTE comprises multiple risk factors that should not be evaluated separately due to collinearity and confoundingDirected Acyclic Graph (DAG) helps to clarify collinearity and confounding related to multiple cause and effect relationships that exist in HA-VTE risk factorsThis is a novel study using DAG-based logistic regression to evaluate risk factors for HA-VTE in childrenWe reported the importance of medical conditions on the genesis of HA-VTE using a DAG-based approach, which makes it possible to clarify the influence of confounders and multiple causalities, such as catheter, a significant risk factor highlighted in several studiesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board (CAAE 58056516.0.0000.5264)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is included in the article and Supplemental material.